Cargando…

Clinical features and treatment of squamous cell carcinoma of the breast

OBJECTIVES: Data on breast squamous cell carcinoma (SCC) are rare. The aim of this study was to analyze the clinical characteristics and to explore the rational treatment of patients with breast SCC. PATIENTS AND METHODS: We conducted a retrospective review of breast SCC cases treated at our center...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ximei, Zhang, Baozhong, Zang, Fenglin, Zhao, Lujun, Yuan, Zhiyong, Wang, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4892827/
https://www.ncbi.nlm.nih.gov/pubmed/27313463
http://dx.doi.org/10.2147/OTT.S95128
_version_ 1782435458027880448
author Zhang, Ximei
Zhang, Baozhong
Zang, Fenglin
Zhao, Lujun
Yuan, Zhiyong
Wang, Ping
author_facet Zhang, Ximei
Zhang, Baozhong
Zang, Fenglin
Zhao, Lujun
Yuan, Zhiyong
Wang, Ping
author_sort Zhang, Ximei
collection PubMed
description OBJECTIVES: Data on breast squamous cell carcinoma (SCC) are rare. The aim of this study was to analyze the clinical characteristics and to explore the rational treatment of patients with breast SCC. PATIENTS AND METHODS: We conducted a retrospective review of breast SCC cases treated at our center from 1966 to 2014. The majority of these patients received primary surgery followed by adjuvant chemoradiotherapy, whilst four elderly patients had lumpectomy only. RESULTS: Patients with breast SCC were usually women, and large masses, large proportion of early stage disease, low levels of estrogen receptor expression, less frequent axillary lymph nodes involvement, and unfavorable prognosis were common. The 5-year overall survival and progression-free survival of all patients were 67.2% and 57.8%, respectively. Axillary nodal involvement was a significant prognostic factor for survival. CONCLUSION: The current results indicated that breast SCC is clinically aggressive and the outcomes were poor. Distant metastasis was the main failure pattern. New strategies will be needed because of the poor outcomes.
format Online
Article
Text
id pubmed-4892827
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-48928272016-06-16 Clinical features and treatment of squamous cell carcinoma of the breast Zhang, Ximei Zhang, Baozhong Zang, Fenglin Zhao, Lujun Yuan, Zhiyong Wang, Ping Onco Targets Ther Original Research OBJECTIVES: Data on breast squamous cell carcinoma (SCC) are rare. The aim of this study was to analyze the clinical characteristics and to explore the rational treatment of patients with breast SCC. PATIENTS AND METHODS: We conducted a retrospective review of breast SCC cases treated at our center from 1966 to 2014. The majority of these patients received primary surgery followed by adjuvant chemoradiotherapy, whilst four elderly patients had lumpectomy only. RESULTS: Patients with breast SCC were usually women, and large masses, large proportion of early stage disease, low levels of estrogen receptor expression, less frequent axillary lymph nodes involvement, and unfavorable prognosis were common. The 5-year overall survival and progression-free survival of all patients were 67.2% and 57.8%, respectively. Axillary nodal involvement was a significant prognostic factor for survival. CONCLUSION: The current results indicated that breast SCC is clinically aggressive and the outcomes were poor. Distant metastasis was the main failure pattern. New strategies will be needed because of the poor outcomes. Dove Medical Press 2016-05-27 /pmc/articles/PMC4892827/ /pubmed/27313463 http://dx.doi.org/10.2147/OTT.S95128 Text en © 2016 Zhang et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Zhang, Ximei
Zhang, Baozhong
Zang, Fenglin
Zhao, Lujun
Yuan, Zhiyong
Wang, Ping
Clinical features and treatment of squamous cell carcinoma of the breast
title Clinical features and treatment of squamous cell carcinoma of the breast
title_full Clinical features and treatment of squamous cell carcinoma of the breast
title_fullStr Clinical features and treatment of squamous cell carcinoma of the breast
title_full_unstemmed Clinical features and treatment of squamous cell carcinoma of the breast
title_short Clinical features and treatment of squamous cell carcinoma of the breast
title_sort clinical features and treatment of squamous cell carcinoma of the breast
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4892827/
https://www.ncbi.nlm.nih.gov/pubmed/27313463
http://dx.doi.org/10.2147/OTT.S95128
work_keys_str_mv AT zhangximei clinicalfeaturesandtreatmentofsquamouscellcarcinomaofthebreast
AT zhangbaozhong clinicalfeaturesandtreatmentofsquamouscellcarcinomaofthebreast
AT zangfenglin clinicalfeaturesandtreatmentofsquamouscellcarcinomaofthebreast
AT zhaolujun clinicalfeaturesandtreatmentofsquamouscellcarcinomaofthebreast
AT yuanzhiyong clinicalfeaturesandtreatmentofsquamouscellcarcinomaofthebreast
AT wangping clinicalfeaturesandtreatmentofsquamouscellcarcinomaofthebreast